← Leaderboards
Sandra M Wells
University Of Montana
$931,145
Attributed
$931,145
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2006–11$250K$187.5K$125K$62.5K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$931,145 · 3
By mechanism
R00$747,000 · 1
K99$97,200 · 1
F32$86,945 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationIn VivoExpectationHomeostasisInflammatoryInhibitor/AntagonistAirway HyperresponsivenessEpithelial CellsEnzymesGenerationsAsthmaAsthmatic PatientChronicBaseBiological AvailabilityBlood CirculationCharacteristicsCardiovascular DiseasesCardiovascular Risk FactorArginaseArginineFunctional DisorderCellsLaboratories
Grant awards (6)
The role of asymmetric dimethylarginine (ADMA) in asthma$249,000
R00 · FY2011 · HL · contact PI
The role of asymmetric dimethylarginine (ADMA) in asthma$249,000
R00 · FY2010 · HL · contact PI
The role of asymmetric dimethylarginine (ADMA) in asthma$249,000
R00 · FY2009 · HL · contact PI
The role of ADMA in the pathology of asthma$97,200
K99 · FY2008 · HL · contact PI
The role of ADMA in the pathology of asthma$28,909
F32 · FY2007 · HL · contact PI
The role of ADMA in the pathology of asthma$58,036
F32 · FY2006 · HL · contact PI